Evidence map›Paper›PMID 37776335›Full record

ArticleParasitology research2023

Comparison of in vitro growth characteristics of Cryptosporidium hominis (IdA15G1) and Cryptosporidium parvum (Iowa-IIaA17G2R1 and IIaA18G3R1).

Samantha Gunasekera, Peta L Clode, Brendon King, Paul Monis, Benjamin Thierry, Jillian M Carr, Abha Chopra, Mark Watson, Mark O'Dea, Nawal Hijjawi and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Parasitology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Efficacy of medicinal plants in cryptosporidiosis treatment: a comprehensive review.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Review
  3. Microphysiological gut-on-chip enables extendedFrontiers in cellular and infection microbiology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Samantha GunasekeraHarry Butler Institute, College of Environmental and Life Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia. s.gunasekera@iiid.murdoch.edu.au.
Peta L ClodeCentre for Microscopy, Characterisation, and Analysis and School of Biological Sciences, The University of Western Australia, Crawley, Western Australia, 6009, Australia.
Brendon KingSouth Australian Water Corporation, Adelaide, South Australia, 5000, Australia.
Paul MonisSouth Australian Water Corporation, Adelaide, South Australia, 5000, Australia.
Benjamin ThierryFuture Industries Institute, University of South Australia, Adelaide, South Australia, 5095, Australia.
Jillian M CarrCollege of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, 5042, Australia.
Abha ChopraImmunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, 6150, Australia.
Mark WatsonImmunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, 6150, Australia.
Mark O'DeaHarry Butler Institute, College of Environmental and Life Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia.
Nawal HijjawiDepartment of Medical Laboratory Sciences, Faculty of Applied Health Sciences, The Hashemite University, P.O. Box 150459, Zarqa, 13115, Jordan.
Una RyanHarry Butler Institute, College of Environmental and Life Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia. una.ryan@murdoch.edu.au.
Murdoch University · AUSouth Australian Water Corporation · AUFlinders University · AUHashemite University · JOUniversity of South Australia · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptosporidium is a major cause of diarrhoeal disease and mortality in young children in resource-poor countries, for which no vaccines or adequate therapeutic options are available. Infection in humans is primarily caused by two species: C. hominis and C. parvum. Despite C. hominis being the dominant species infecting humans in most countries, very little is known about its growth characteristics and life cycle in vitro, given that the majority of our knowledge of the in vitro development of Cryptosporidium has been based on C. parvum. In the present study, the growth and development of two C. parvum isolates (subtypes Iowa-IIaA17G2R1 and IIaA18G3R1) and one C. hominis isolate (subtype IdA15G1) in HCT-8 cells were examined and compared at 24 h and 48 h using morphological data acquired with scanning electron microscopy. Our data indicated no significant differences in the proportion of meronts or merozoites between species or subtypes at either time-point. Sexual development was observed at the 48-h time-point across both species through observations of both microgamonts and macrogamonts, with a higher frequency of macrogamont observations in C. hominis (IdA15G1) cultures at 48-h post-infection compared to both C. parvum subtypes. This corresponded to differences in the proportion of trophozoites observed at the same time point. No differences in proportion of microgamonts were observed between the three subtypes, which were rarely observed across all cultures. In summary, our data indicate that asexual development of C. hominis is similar to that of C. parvum, while sexual development is accelerated in C. hominis. This study provides new insights into differences in the in vitro growth characteristics of C. hominis when compared to C. parvum, which will facilitate our understanding of the sexual development of both species.

Indexed as

CryptosporidiosisCryptosporidiumCryptosporidium parvumAnimalsChildChild, PreschoolHumansIowaLife Cycle StagesC. hominisC. parvumCryptosporidiumIn vitroLife cycleScanning electron microscopy

Identifiers

PMID37776335
PMCPMC10667462
OpenAlexW4387221169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.